My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
September 2014
Top Stories
IDSA Provides Ebola Resources for ID Clinicians
In an effort to keep our members current with the evolving Ebola outbreak in West Africa and prepared for any potential US response, IDSA has compiled numerous resources on the homepage of our website including:

IDWeek, Oct. 8-12 in Philadelphia, will include timely updates on Ebola, including perspectives from physicians and scientists who have been involved with the response in West Africa and the US.

In addition to providing these resources to our members, IDSA has also coordinated responses to several media inquiries about the outbreak. Thanks to the help of members of the Public Health Committee, we have been able to provide a science-based perspective to the general public’s understanding of the outbreak, the medical response, and the likelihood of the virus appearing in the US. In a recent story appearing in Salon, Jeff Duchin, MD, FIDSA, chair of IDSA’s Public Health Committee responded to a recent Harvard School of Public Health survey showing that over a quarter of Americans fear that they or someone in their family could become infected with the virus, explaining that the chances of a US outbreak are close to zero.

Additional Resources and Requests:

Oxford University Press
, publisher of IDSA journals, has a collection of journal articles on Ebola, available free of charge at:

Centers for Disease Control and Prevention Advice for Humanitarian Aid Workers Traveling to Guinea, Liberia, Nigeria, or Sierra Leone during the Ebola Outbreak

Doctors Without Borders/ Médecins Sans Frontières (MSF) is actively looking for medical personnel who can assist with the Ebola crisis in West Africa. They are looking for nurses and physicians with experience working in isolation wards and infection control. To learn more about the qualifications needed or to apply visit the Doctors Without Borders website.  

Sign Up for Alerts

Much of the information provided above was shared with IDSA members through the two email services offered to help members stay informed of updates from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). Content includes a range of topics, including new drug approvals and warnings. Other recent alerts have included:

Cubist Pharmaceuticals Issues Voluntary U.S. Recall Of Certain Lots Of CUBICIN

FDA approves Orbactiv to treat skin infections

IDSA members can log in to MyIDSA to sign up for these services online.

Is Your Facility Experiencing Antibiotic Shortages?

IDSA members are urged to report drug shortages directly to FDA and to copy IDSA staff at

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:

Patient Care and Science
Sanford Guide Releases Mobile App for Lab Diagnosis of Infectious Diseases
NVAC Standards for Adult Immunization: What Do They Mean for the ID Specialist?
HCV Treatment Guidance Now Includes Information on Prioritizing Patients
Clinical Practice Management
New Resources on Co-management Agreements and Antimicrobial Stewardship Now Available
IDSA, HIVMA Appeal Medicaid Restrictions on Who Treats HCV
Policy and Advocacy
IDSA Convenes New National Stakeholder Group on Antimicrobial Resistance
Federal Funding Process Stalled Just Weeks Ahead of New Fiscal Year
Health Groups Share Federal Funding Experiences with Congress
Advocacy on New Antibacterial Drug Pathway Continues in the House
IDSA Submits Comments to FDA on Draft Guidance on Diagnostics
Global ID
Highlights from 20th International AIDS Conference
Education and Resources
Concerns Regarding Changes to MOC Requirements Shared with ABIM
IDSA Education and Research Foundation Launches New Website
Sign Up for OFID Table of Contents Alerts
You and Your Colleagues
In Memoriam: Gene H. Stollerman, MD, FIDSA (1920-2014)
IDSA Announces 2014 Fellows
Members on the Move
New Members
Top Stories
Presidentís Message: With the Spotlight on Drug Resistance, Itís Time for the ID Specialistís Role in Stewardship to Shine
IDSA Provides Ebola Resources for ID Clinicians
Countdown to IDWeek 2014
IDSA Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.